Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

HYPR

Hyperfine (HYPR)

Hyperfine Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:HYPR
DateHeureSourceTitreSymboleSociété
25/06/202415h00Business WireClinical Research Using Swoop® System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimer’s Association International ConferenceNASDAQ:HYPRHyperfine Inc
12/06/202422h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HYPRHyperfine Inc
03/06/202422h05Business WireHyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024NASDAQ:HYPRHyperfine Inc
28/05/202415h00Business WireHyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to IndiaNASDAQ:HYPRHyperfine Inc
22/05/202422h05Business WireHyperfine, Inc. to Present at the Jefferies Global Healthcare ConferenceNASDAQ:HYPRHyperfine Inc
22/05/202415h00Business WireHyperfine, Inc. Celebrates ASNR 2024NASDAQ:HYPRHyperfine Inc
16/05/202423h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HYPRHyperfine Inc
14/05/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HYPRHyperfine Inc
13/05/202422h05GlobeNewswire Inc.Hyperfine, Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:HYPRHyperfine Inc
10/05/202415h00Business WireHyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European MarketsNASDAQ:HYPRHyperfine Inc
29/04/202422h05Business WireHyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:HYPRHyperfine Inc
23/04/202415h00Business WireHyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical ConditionsNASDAQ:HYPRHyperfine Inc
17/04/202415h00Business WireLeading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR StudyNASDAQ:HYPRHyperfine Inc
21/03/202421h05GlobeNewswire Inc.Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:HYPRHyperfine Inc
21/03/202412h26IH Market NewsU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor DeclinesNASDAQ:HYPRHyperfine Inc
12/03/202414h00Business WireHyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess RoyalNASDAQ:HYPRHyperfine Inc
07/03/202422h30Business WireHyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024NASDAQ:HYPRHyperfine Inc
28/02/202422h30Business WireHyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare ConferenceNASDAQ:HYPRHyperfine Inc
21/02/202415h00Business WireHyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional AthletesNASDAQ:HYPRHyperfine Inc
01/02/202414h00Business WireHyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational StudyNASDAQ:HYPRHyperfine Inc
09/01/202415h00Business WireHyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of UseNASDAQ:HYPRHyperfine Inc
24/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HYPRHyperfine Inc
21/11/202300h20Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:HYPRHyperfine Inc
20/11/202315h00Business WireHyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023NASDAQ:HYPRHyperfine Inc
16/11/202315h00Business WireHyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:HYPRHyperfine Inc
09/11/202322h43Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:HYPRHyperfine Inc
09/11/202322h05GlobeNewswire Inc.Hyperfine, Inc. Reports Third Quarter 2023 Financial ResultsNASDAQ:HYPRHyperfine Inc
02/11/202314h15Business WireObservational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO PatientsNASDAQ:HYPRHyperfine Inc
19/10/202322h05Business WireHyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023NASDAQ:HYPRHyperfine Inc
10/10/202322h05Business WireHyperfine, Inc. Announces Promotions of Two Key Clinical Affairs ExecutivesNASDAQ:HYPRHyperfine Inc
 Showing the most relevant articles for your search:NASDAQ:HYPR